Literature DB >> 21969017

Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis.

Matthew R Reynolds1, Elizabeth A Magnuson, Yang Lei, Martin B Leon, Craig R Smith, Lars G Svensson, John G Webb, Vasilis C Babaliaros, Bruce S Bowers, William F Fearon, Howard C Herrmann, Samir Kapadia, Susheel K Kodali, Raj R Makkar, Augusto D Pichard, David J Cohen.   

Abstract

Background- Transcatheter aortic valve replacement (TAVR) has been shown to improve survival compared with standard therapy in patients with severe aortic stenosis who cannot have surgery. The effects of TAVR on health-related quality of life have not been reported from a controlled study. Methods and Results- The Placement of Aortic Transcatheter Valves (PARTNER) trial randomized patients with symptomatic, severe aortic stenosis who were not candidates for surgical valve replacement to TAVR (n=179) or standard therapy (n=179). Health-related quality of life was assessed at baseline and at 1, 6, and 12 months with the Kansas City Cardiomyopathy Questionnaire (KCCQ) and the 12-item Short Form-12 General Health Survey (SF-12). The primary end point was the KCCQ overall summary score (range, 0-100; higher=better). At baseline, mean KCCQ summary scores (35±20) and SF-12 physical summary scores (28±7) were markedly depressed. Although the KCCQ summary score improved from baseline in both groups, the extent of improvement was greater after TAVR compared with control at 1 month (mean between-group difference, 13 points; 95% confidence interval, 8-19; P<0.001) with larger benefits at 6 months (mean difference, 21 points; 95% confidence interval, 15-27; P<0.001) and 12 months (mean difference, 26 points; 95% confidence interval, 19-33; P<0.001). At 12 months, TAVR patients also reported higher SF-12 physical and mental health scores with mean differences compared with standard care of 5.7 and 6.4 points, respectively (P<0.001 for both comparisons). Conclusions- Among inoperable patients with severe aortic stenosis, compared with standard care, TAVR resulted in significant improvements in health-related quality of life that were maintained for at least 1 year. Clinical Trials Registration- URL: http://www.clinicaltrials.gov. Unique identifier: NCT00530894.

Entities:  

Mesh:

Year:  2011        PMID: 21969017     DOI: 10.1161/CIRCULATIONAHA.111.040022

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  74 in total

1.  Validity of standard gamble utilities in patients referred for aortic valve replacement.

Authors:  Amjad I Hussain; Andrew M Garratt; Jan Otto Beitnes; Lars Gullestad; Kjell I Pettersen
Journal:  Qual Life Res       Date:  2015-11-24       Impact factor: 4.147

2.  How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial.

Authors:  Suzanne V Arnold; John A Spertus; Yang Lei; Philip Green; Ajay J Kirtane; Samir Kapadia; Vinod H Thourani; Howard C Herrmann; Nirat Beohar; Alan Zajarias; Michael J Mack; Martin B Leon; David J Cohen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-09-10

3.  Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry.

Authors:  Suzanne V Arnold; John A Spertus; Sreekanth Vemulapalli; Zhuokai Li; Roland A Matsouaka; Suzanne J Baron; Amit N Vora; Michael J Mack; Matthew R Reynolds; John S Rumsfeld; David J Cohen
Journal:  JAMA Cardiol       Date:  2017-04-01       Impact factor: 14.676

4.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

5.  Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: Outcomes of a decision-analytic model.

Authors:  Hemal Gada; Shikhar Agarwal; Thomas H Marwick
Journal:  Ann Cardiothorac Surg       Date:  2012-07

Review 6.  Will catheter interventions replace surgery for valve abnormalities?

Authors:  Michael L O'Byrne; Matthew J Gillespie
Journal:  Curr Opin Cardiol       Date:  2014-01       Impact factor: 2.161

Review 7.  Frailty in cardiothoracic surgery: systematic review of the literature.

Authors:  Hiroshi Furukawa; Kazuo Tanemoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-04-28

8.  Relationship Between Accelerometer-Measured Activity and Self-Reported or Performance-Based Function in Older Adults with Severe Aortic Stenosis.

Authors:  Yufei Tang; Philip Green; Mathew Maurer; Rosa Lazarte; Jonathan Rubin Kuzniecky; Ming Yang Hung; Melissa Garcia; Susheel Kodali; Tamara Harris
Journal:  Curr Geriatr Rep       Date:  2015-10-14

9.  Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population.

Authors:  Suzanne V Arnold; David J Cohen; David Dai; Philip G Jones; Fan Li; Laine Thomas; Suzanne J Baron; Naftali Z Frankel; Susan Strong; Roland A Matsouaka; Fred H Edwards; J Matthew Brennan
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-10

10.  Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement.

Authors:  Suzanne J Baron; Suzanne V Arnold; Howard C Herrmann; David R Holmes; Wilson Y Szeto; Keith B Allen; Adnan K Chhatriwalla; Sreekaanth Vemulapali; Sean O'Brien; Dadi Dai; David J Cohen
Journal:  J Am Coll Cardiol       Date:  2016-05-24       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.